Phase 1 trial of CSIR-IMTECH’s clot buster to start by end October
Ahmedabad's Veeda CR to conduct the trial, CSIR aims to launch drug in India by 2014
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Vayalar Ravi takes additional charge of Ministry of Science & Technology
Overseas Indian Affairs Minister Vayalar Ravi has been given the additional charge of the Ministry of Science & Technology, as…
US FDA clears Claris Lifesciences’ facility after remedial action
Approval allows Claris to re-enter US market
Gearing up for the biosimilar boom
Viveka Roychowdhury seeks reactions of industry players to DBT's draft biosimilar guidelines and analyses whether it can serve as…
DCGI asks CDSCOs offices to ensure implementation of ban on serodiagnostic test kits
Post the ban on serodiagnostic test kits, the Drug Controller General (India) (DCGI) has requested zonal, sub zonal, port offices…
M&A activity in the pharma sector decreases in both volume and value terms
The pharma sector recorded 27 M&A transactions in July 2012, against the previous six months’ average of 49 transactions
Pharmexcil and MHLW, Japan to promote generic drugs
Invites Indian pharma players to supply drugs at affordable price
CDSCO calls for suggestions on draft guidelines for compensating clinical trial victims
Recommendations to be submitted before September 2, 2012
Commerce Ministry to discuss issues on non-tariff barriers in pharma industry with US and EU
Pharma industry to form committee of all industry representatives
Q1 results registers ups and downs in Indian pharma sector
Indian pharma companies have recently released Q1 results, Express Pharma highlights the Q1 performance